Management of melanoma in patients with chronic lymphocytic leukemia

Leukemia Research
William J ArchibaldClive S Zent

Abstract

Melanoma is significantly more common and is associated with a poorer prognosis in patients with an underlying B-cell malignancy. This study reports on the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) and a subsequent diagnosis of melanoma. In the Wilmot Cancer Institute CLL cohort, which includes 470 patients followed for 2849 person-years, 18 patients (3.8%) developed 22 melanomas. Fourteen melanomas were invasive, a significantly higher rate as compared with the age and sex matched general population (standardized incidence ratio [SIR] 6.32 (95% CI 3.45; 10.60). Melanomas were most often detected (n = 15; 68.2%) through active surveillance in a dermatology clinic. Most melanomas (n = 17; 77.3%) were detected at a non-advanced stage (pathological stage grouping < III). The most common management was wide local excision without sentinel lymph node biopsy (n = 13, 59.1%). Management for the 4 (18.2%) patients with metastatic disease included the immune checkpoint inhibitor (ICI) pembrolizumab (n = 1), systemic chemotherapy with dacarbazine (n = 1), and palliative care (n = 2). The patient treated with ICI is in sustained remission of her melanoma after 23 cycles of therapy while her ...Continue Reading

References

Apr 5, 1997·Annals of the New York Academy of Sciences·K J CampagnaM D Chang
Jan 3, 2001·The New England Journal of Medicine·H DöhnerP Lichter
May 10, 2007·Leukemia & Lymphoma·Ewa Robak, Tadeusz Robak
Feb 15, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jerry D BrewerTimothy G Call
May 31, 2013·American Journal of Hematology·Michael Hallek
Dec 3, 2014·Journal of the American Academy of Dermatology·Shannon FameniniJashin J Wu
Jun 19, 2015·Blood·Francesco Forconi, Paul Moss
Sep 21, 2016·Journal of the American Academy of Dermatology·José Antonio Avilés-IzquierdoPablo Lazaro-Ochaita
Aug 24, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·M ArenbergerovaH Frankova
Apr 17, 2018·Journal of the National Cancer Institute·Megan M HerrLindsay M Morton

❮ Previous
Next ❯

Citations

Dec 9, 2020·Journal of Immunotherapy·James W SmithyMargaret K Callahan
Nov 11, 2020·Journal of the American Society of Cytopathology : JASC·Alexander D Fitzthum, Paul E Wakely
Dec 11, 2021·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Emilee A Herringshaw, Mary E Maloney

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.